Skip to content Back to top
 

FOI 2026/1794

Reference FOI 2026/1794
Description Treatment guidelines for Chronic Kidney Disease/Diabetic Kidney disease, Type 2 Diabetes, & Heart Failure
Date Requested 01/06/2026
Date Replied 24/06/2026
Category Medicines Optimisation

Following a search of your website and that of any formularies your organisation is associated with, we have been unable to identify any published guidelines for the treatment of the following conditions. Please could you confirm if NHS Greater Manchester ICB has any local guidelines for the treatment of these conditions.

 

1. Chronic Kidney Disease/Diabetic Kidney disease
Has NHS Greater Manchester ICB published or updated any guidelines for the treatment of chronic kidney disease or diabetic kidney disease since June 2023? Yes
No
If yes please provide a copy
2. Type 2 Diabetes
Has NHS Greater Manchester ICB published or updated any guidelines for the treatment type 2 diabetes since June 2023?
(Note: We are focused on guidelines for the pharmaceutical control of blood sugars rather than guidelines for the management of diabetic patients prior to hospital procedures etc)
Yes
No
If yes please provide a copy
3. Heart Failure
Has NHS Greater Manchester ICB published or updated any guidelines for the treatment of heart failure with reduced, preserved or mildly reduced ejection fraction since June 2023? Yes
No
If yes please provide a copy

 

 

  1. Chronic Kidney Disease/Diabetic Kidney disease – No
  2. Type 2 Diabetes: Yes

GMMMG-NG28-holding-statement-March-26-final-for-web.pdf

GMMMG-Incretin-statement-March-26-final-for-web.pdf

SGLT2-inhibitor-pathway-v1.0-March-2026-for-web.pdf

SGLT2-inhibitor-GM-position-statement-v1.0-March-2026.pdf

  1. Heart Failure – Yes

**A PDF document was sent to the requester with this response.  If you require a copy of the full response, together with the attachments, please contact NHS GM’s FOI team – nhsgm.foi@nhs.net **

Please note the names of individuals have been removed from the document, this information is exempt from disclosure under section 40 (2) of the Freedom of Information Act 2000 as it constitutes personal data where disclosure would be in breach of the Data Protection Act 2018. As section 40 (2) is an absolute exemption there is no duty to consider disclosure in the public interest. They are set out in Part II of the Freedom of Information Act 20

 

Return to FOI Requests

Launch Recite Me assistive technology